Bristol Myers to close cell therapy site in Illinois as part of ongoing cost cuts
Bristol Myers Squibb is ending operations at a viral vector production site in the Chicago suburbs, a spokesperson for the company confirmed to Endpoints News …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.